1. Highlight selection of radiochemistry and radiopharmacy developments by editorial board
- Author
-
Bernardes, Emerson, Caravan, Peter, van Dam, Michael, Winnie, Deuther-Conrad, Ellis, Beverly, Shozo, Furumoto, Guillet, Benjamin, Ya-Yao, Huang, Jia, Hongmei, Laverman, Peter, Li, Zijing, Liu, Zhaofei, Lodi, Filippo, Miao, Yubin, Perk, Lars, Schirrmacher, Ralf, Vercoullie, Johnny, Yang, Hua, Yang, Min, Yang, Xing, Zhang, Junbo, Zhang, Ming-Rong, Zhu, Hua, Bernardes, Emerson, Caravan, Peter, van Dam, Michael, Winnie, Deuther-Conrad, Ellis, Beverly, Shozo, Furumoto, Guillet, Benjamin, Ya-Yao, Huang, Jia, Hongmei, Laverman, Peter, Li, Zijing, Liu, Zhaofei, Lodi, Filippo, Miao, Yubin, Perk, Lars, Schirrmacher, Ralf, Vercoullie, Johnny, Yang, Hua, Yang, Min, Yang, Xing, Zhang, Junbo, Zhang, Ming-Rong, and Zhu, Hua
- Abstract
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Conclusion: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
- Published
- 2022